Literature DB >> 21767923

Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005-2010.

Serge Schneider1, François Meys.   

Abstract

This article discusses drug purity, frequency of appearance and concentration ranges of adulterants of 471 illicit cocaine and 962 illicit heroin samples seized in Luxembourg from January 2005 to December 2010. For cocaine samples the mean concentration was lowest in 2009 (43.2%) and highest in 2005 (54.7%) but no clear trend could be observed during the last 6 years. 14 different adulterants have been detected in cocaine samples, from which phenacetin has been the most abundant in terms of frequency of appearance and concentration until 2009. In 2010 the veterinary antihelminthic drug levamisole has become the most abundant adulterant detected in cocaine samples, its concentrations however remained low (1.5-4.1%). The mean heroin concentration was 26.6% in 2005, a decline has been observed in 2006 and the concentrations have been relatively stable since then (15.8-17.4%). Paracetamol and caffeine were by far the most abundant adulterants detected in heroin samples.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21767923     DOI: 10.1016/j.forsciint.2011.06.027

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  10 in total

1.  Dual-energy CT behavior of heroin, cocaine, and typical adulterants.

Authors:  Patrick J Laberke; Juergen Fornaro; Suk-kyum Kim; Simon Blum; Marc Augsburger; Hatem Alkadhi; Simon Wildermuth; Roland Hausmann; Sebastian Leschka
Journal:  Forensic Sci Med Pathol       Date:  2015-01-08       Impact factor: 2.007

2.  The hairy-print for levamisole-induced vasculitis.

Authors:  Hélène Lazareth; Gilles Peytavin; Laura Polivka; Nicolas Dupin
Journal:  BMJ Case Rep       Date:  2012-08-08

3.  Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge.

Authors:  Kachiu C Lee; Barry Ladizinski; Daniel G Federman
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

4.  Quinine enhances the behavioral stimulant effect of cocaine in mice.

Authors:  Adriana Huertas; William D Wessinger; Yuri V Kucheryavykh; Priscila Sanabria; Misty J Eaton; Serguei N Skatchkov; Legier V Rojas; Gerónimo Maldonado-Martínez; Mikhail Y Inyushin
Journal:  Pharmacol Biochem Behav       Date:  2014-12-05       Impact factor: 3.533

5.  Candyflipping and Other Combinations: Identifying Drug-Drug Combinations from an Online Forum.

Authors:  Michael Chary; David Yi; Alex F Manini
Journal:  Front Psychiatry       Date:  2018-04-30       Impact factor: 4.157

6.  The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs.

Authors:  Stephanie Lake; Kanna Hayashi; Jane Buxton; M-J Milloy; Huiru Dong; Evan Wood; Julio Montaner; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2015-09-30       Impact factor: 4.492

Review 7.  Cocaine adulteration.

Authors:  Oliver Kudlacek; Tina Hofmaier; Anton Luf; Felix P Mayer; Thomas Stockner; Constanze Nagy; Marion Holy; Michael Freissmuth; Rainer Schmid; Harald H Sitte
Journal:  J Chem Neuroanat       Date:  2017-06-12       Impact factor: 3.097

8.  Occurrence of bacterial and toxic metals contamination in illegal opioid-like drugs in Iran: a significant health challenge in drug abusers.

Authors:  Rassoul Aghababaei; Iraj Javadi; Amir Nili-Ahmadabadi; Somayeh Parsafar; Davoud Ahmadimoghaddam
Journal:  Daru       Date:  2018-06-29       Impact factor: 3.117

9.  Intriguing Cytotoxicity of the Street Dissociative Anesthetic Methoxphenidine: Unexpected Impurities Spotted.

Authors:  Bronislav Jurásek; Silvie Rimpelová; Martin Babor; Jan Čejka; Vilém Bartůněk; Martin Kuchař
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

10.  Invited Commentary: Drug Checking for Novel Insights Into the Unregulated Drug Supply.

Authors:  Nabarun Dasgupta; Mary C Figgatt
Journal:  Am J Epidemiol       Date:  2022-01-24       Impact factor: 4.897

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.